First Innovation Alliance to receive approval letter

06-03-2013

As the industrial coordinator of the innovation alliance, the biotechnology company BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance is the first alliance to receive the official approval letter under the “Industrial Biotechnology ...

more

17-12-2012

BRAIN AG has announced the expansion of its IP portfolio to include the MMPI (matrix metalloproteinase inhibitor) peptide. Now owned by BRAIN, the recombinant human bioactive molecule will be manufactured by BRAIN as a proprietary bioactive compound going forward and exclusively used in ...

more

20-11-2012

The supervisory board and the board of management of the biotechnology company BRAIN AG agreed on a €60m capital increase during a meeting of the supervisory board held on 19 November 2012. The capital increase helps pave the way for the implementation of BRAIN’s “buy-and-build” ...

more

09-08-2012

Evonik Industries AG and BRAIN AG co-operate in the field of the development of novelmicroorganisms with unique, selective binding- and adsorption characteristics on selected surfaces. Within the co-operation the partners pursue the joint objective of identifying and developing suitable ...

more

21-06-2012

BRAIN AG has announced that the Natural Life Excellence Network 2020 (NatLifE 2020) innovation alliance will be funded by the Federal Ministry of Education and Research (BMBF) under the “Industrial Biotechnology Innovation Initiative” scheme. The official announcement has been made by ...

more

15-05-2012

BRAIN AG announced the granting of a European patent in the field of biotechnological wound conditioning. This new substance patent, registered under the official number EP2245150 B1, was invented by BRAIN within the scope of a BMBF supported research program (FKZ: 0313916). The patent ...

more

Immortalized Human Taste Cell Lines Provide New Insights into Taste Reception and Help Improve Nutraceutical Development

02-05-2012

BRAIN AG discloses a breakthrough in human cellbased assay technology to identify and develop novel taste modulators and nutraceuticals. For the first time, researchers at BRAIN succeeded in establishing immortalized primary human taste cell lines derived from taste papillae of the human ...

more

02-03-2012

BRAIN AG and the cosmetics company Wilde Cosmetics GmbH have announced a strategic partnership with regard to MONTEIL Cosmetics International GmbH. The partners agree to co-operate in the development and marketing of innovative cosmetics products in an unprecedented alliance of two ...

more

05-01-2012

Tailor-made specialist micro-organisms directly “feed” on CO2-containing flue gases from lignitefired power stations and even grow at temperatures of 60 degrees centigrade. This is the very promising initial result of a research project run in co-operation by RWE Power and BRAIN AG. The ...

more

07-03-2011

BRAIN AG and the DECHEMA Society for Chemical Engineering and Biotechnology in Frankfurt have announced a collaboration in the biotechnological production of perillic acid. This patented natural monoterpene is owned by BRAIN and will be used in a wide range of applications as a bioactive ...

more